1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 5: Nonvisible findings—visual analysis results for GMC^{^a}
Models All Lobes (%)
Controls Patients
T1 53.2 61.5
T1+T2 45.2 30.8
T1+FLAIR 50.0 61.5
T1+T2+FLAIR 48.4 46.2
↵a Rates of findings not visible—that is, unclear findings in controls and unclear/potentially epileptogenic and not visible findings in patients across all models for all lobes (%) are reported.
Models	All Lobes (%)
Models	Controls	Patients
T1	53.2	61.5
T1+T2	45.2	30.8
T1+FLAIR	50.0	61.5
T1+T2+FLAIR	48.4	46.2